Oaktree Acquisition Corp. III Life Sciences (OACCU) Return on Equity (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACCU) reported Return on Equity of 0.01% for Q1 2026, up 6.81% quarter-over-quarter from 0.01% in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACCU) Return on Equity (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Return on Equity for 2 years, with the latest figure at 0.01% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Equity changed N/A year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed N/A YoY), and the FY2025 full-year result was 0.01%, changed N/A from the prior year.
  • Return on Equity for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
  • The five-year high for Return on Equity was 0.01% in Q3 2025, with the low at 0.01% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -0.01%
2 Berto Acquisition 312.16 Mn 312.16 Mn - -0.01%
3 Centurion Acquisition 311.79 Mn 311.79 Mn - -0.01%
4 Churchill Capital Corp IX 309.64 Mn 309.64 Mn - -0.01%
5 WEN Acquisition 308.55 Mn 308.55 Mn - -0.01%
6 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn - 0.00%
7 Bold Eagle Acquisition 274.25 Mn 274.25 Mn - -0.01%
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - 0.00%
9 BTC Development 263.21 Mn 263.21 Mn - 0.00%
10 Oaktree Acquisition Corp. III Life Sciences - - - -0.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%